ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "COVID-19"

  • Abstract Number: 1339 • ACR Convergence 2022

    Impact of the COVID-19 Pandemic on Patients with Rheumatoid Arthritis: Data from the Ontario Best Practices Research Initiative (OBRI)

    Matthew Wong-Pack1, Elliot Hepworth2, Mohammad Movahedi3, Bindee Kuriya1, Janet Pope4, Edward Keystone5, Carter Thorne6, VANDANA AHLUWALIA7, Angela Cesta8, Carol Mously8, Claire Bombardier1, Arthur Lau9 and Sibel Aydin10, 1University of Toronto, Toronto, ON, Canada, 2University of Ottawa, Ottawa, ON, Canada, 3Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada, 4University of Western Ontario, London, ON, Canada, 5Keystone Consulting Enterprises Inc., Toronto, ON, Canada, 6Southlake Regional Health Centre, Newmarket, ON, Canada, 7William Osler Health System, Brampton, ON, Canada, 8University Health Network, Toronto, ON, Canada, 9McMaster University, Hamilton, ON, Canada, 10University of Ottawa, Rheumatology, Ottawa, Canada, Ottawa, ON, Canada

    Background/Purpose: The COVID-19 Pandemic created challenges for patients with rheumatoid arthritis (RA), including accessing the health care system, transition to unplanned virtual care, reduction in…
  • Abstract Number: 1776 • ACR Convergence 2022

    COVID-19 Cases in Patients Treated with Secukinumab: Analysis from the Global Safety Database

    Atul Deodhar1, Andrew Blauvelt2, Philip J Mease3, Effie Pournara4, Piotr Jagiello4, Weibin Bao5 and Abhishek Sharma6, 1Oregon Health & Science University, Portland, OR, USA, Portland, OR, 2Oregon Medical Research Center, Portland, OR, USA, Portland, OR, 3Swedish Medical Center/Providence St. Joseph Health, Seattle, WA, 4Novartis Pharma AG, Basel, Switzerland, 5Novartis Pharmaceuticals Corporation, East Hanover, NJ, 6Novartis Healthcare Pvt. Ltd, Hyderabad, India

    Background/Purpose: Although patients (pts) with immune-mediated inflammatory diseases who are taking immunosuppressive therapies are not at a significantly greater risk of SARS-CoV-2 (severe acute respiratory…
  • Abstract Number: 1949 • ACR Convergence 2022

    Effectiveness of the BNT162b2 mRNA COVID-19 Vaccine Among Adolescents with Juvenile-onset Inflammatory Rheumatic Diseases

    amit ziv1, Merav Heshin-Bekenstein2, Ruby Haviv3, Shaye Kivity4, doron netzer5, shlomit yaron5, yoav schur5, tsipi egert6, yona egert6, yaron sela7, Philip Hashkes8 and Yosef Uziel9, 1Meir Hospital, Kfar Saba, Israel, 2Dana Dwek Children's Hospital, Tel Aviv Medical Center Israel, Binyamina, Israel, 3Meir Medical Center, Ra'Anana, Israel, 4Meir Medical Center, Kefar Saba, Israel, 5Community Medical Services Division, Clalit Health Services, Tel Aviv, Israel, 6Inbar, NPO, Ramat Gan, Israel, 7The Research Center for Internet Psychology, School of Communications, Reichman University, Herzliya, Israel, 8Shaare Zedek Medical Center, Jerusalem, Israel, 9Meir Medical Center, Kfar Saba; Sackler School of Medicine, Tel Aviv University, Kfar Saba, Israel

    Background/Purpose: Effectiveness of the BNT162b2 mRNA COVID-19 vaccine for adolescents with juvenile-onset inflammatory rheumatic diseases (IRD) is unknown. Several studies suggested attenuated immunogenicity in patients…
  • Abstract Number: 2274 • ACR Convergence 2022

    Factors Associated with Disease Flare Following SARS-CoV-2 Vaccination in People with Inflammatory Rheumatic and Musculoskeletal Diseases – Results from the Physician-Reported EULAR Coronavirus Vaccine (COVAX) Registry

    Bayram Farisoğulları1, Saskia Lawson-Tovey2, Kimme Hyrich3, Laure Gossec4, Loreto Carmona5, Anja Strangfeld6, Elsa Mateus7, Martin Schaefer8, Ana Maria Rodrigues9, Eric Hachulla10, Jose A Gomez-Puerta11, Marta Mosca12, Patrick Durez13, Ludovic Trefond14, Tiphaine Goulenok15, Martina Cornalba16, Emoke Šteňová17, Inita Bulina18, Eva Strakova19, Julija Zepa20, Nicolas Roux21, Olivier Brocq22, Viellard Eric23, Bernd Raffeiner24, Gerd Burmester25, Xavier Mariette26 and Pedro Machado27, 1Hacettepe University Faculty of Medicine Division of Rheumatology, Ankara, Turkey, 2Centre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, the University of Manchester, Manchester, UK AND National Institute of Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom, 3The University of Manchester, Manchester, United Kingdom, 4Sorbonne Université, Paris, France, 5Instituto de Salud Musculoesquelética (InMusc), Madrid, Spain, 6Deutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany, 7EULAR, Lisboa, Portugal, 8German Rheumatism Research Center, Berlin, Germany, 9Reuma.pt, Sociedade Portuguesa de Reumatologia, Lisbon, Portugal, 10University of Lille, LILLE, France, 11Hospital Clínic de Barcelona, Barcelona, Spain, 12Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy, 13Rheumatology, Cliniques Universitaires Saint-Luc – Université catholique de Louvain (UCLouvain) – Institut de Recherche Expérimentale et Clinique (IREC), Brussels, Belgium, 14Université Clermont Auvergne, CHU Clermont-Ferrand, Service de Médecine Interne, Hôpital Gabriel Montpied, INSERM U1071, Clermont-Ferrand, France, 15APHP, Paris, France, 16Dipartimento di Reumatologia e Scienze Mediche, ASST Gaetano Pini-CTO, Milano, Italy, 17University Hospital, Bratislava, Slovakia, 18Center of Rheumatology, Paul Stradins Clinical University hospital, Riga, Latvia, Riga, Latvia, 19Department of Internal Medicine, Faculty Hospital Prešov, Presov, Slovakia, 20Riga Stradins University, Latvia, Pauls Stradins Clinical University Hospital, Centre of Rheumatology, Riga, Latvia, Riga, Latvia, 21Service de Rhumatologie, Hôpital Robert Schuman, Metz, France, 22Rheumatology- CH Princesse Grace, Monaco, Monaco, 23Private practice, St. Malo, France, 24Department of Rheumatology, Central Hospital of Bolzano, Bolzano, Italy, 25Charité University Medicine Berlin, Berlin, Germany, 26Paris-Saclay University, Rueil Malmaison, Ile-de-France, France, 27University College London, London, United Kingdom

    Background/Purpose: To investigate the frequency and factors associated with disease flare following vaccination against SARS-CoV-2 in people with inflammatory/autoimmune rheumatic and musculoskeletal diseases (I-RMD).Methods: The…
  • Abstract Number: 0081 • ACR Convergence 2022

    Impact of the COVID-19 Pandemic on Rheumatology Services in a Universal Healthcare Setting in Canada: A Population-based Study

    Timothy Kwok1, Bindee Kuriya1, Lauren King1, Lihi Eder2, Carter Thorne3, Zhiyin Li4, therese stukel4, longdi fu4, alexander Kopp4 and Jessica Widdifield5, 1University of Toronto, Toronto, ON, Canada, 2Women’s College Research Institute, Department of Medicine, University of Toronto, Toronto, ON, Canada, 3Southlake Regional Health Centre, Newmarket, ON, Canada, 4ICES, Toronto, ON, Canada, 5Sunnybrook Research Institute, Toronto, ON, Canada

    Background/Purpose: We sought to describe changes in service delivery and access to rheumatologists in terms of changes in weekly total office visit volumes, telemedicine visits,…
  • Abstract Number: 0270 • ACR Convergence 2022

    Lower mRNA-anti SARS-Cov2 Induced IgG Antibody Responses to S1, S2 and RBD May Result from a Delayed IgA and IgM Class Switch in Patients with Rheumatoid Arthritis

    Kristin Schmiedeberg1, Irene Abela2, Nicolas Vuilleumier3, Johannes von Kempis4 and Andrea Rubbert-Roth5, 1Cantonal Hospital St Gallen, St.Gallen, Switzerland, 2Institute of Medical Virology, University of Zurich, Zürich, Switzerland, 3Laboratory Medicine Division, University of Geneva, Geneva, Switzerland, 4Division of Rheumatology, Cantonal Hospital St.Gallen, St. Gallen, Switzerland, 5Division of Rheumatology, Cantonal Clinic St Gallen, St.Gallen, Switzerland

    Background/Purpose: Anti-SARS-CoV2 mRNA vaccination may result in blunted humoral immune responses with lower peak titers and a different kinetic in patients with rheumatic diseases receiving…
  • Abstract Number: 0710 • ACR Convergence 2022

    Risk Factors Associated with COVID-19 Breakthrough Infection Among Patients with Systemic Autoimmune Rheumatic Diseases: A Cohort Study

    Naomi Patel1, Xiaosong Wang2, Xiaoqing Fu3, Yumeko Kawano2, Claire Cook3, Kathleen Vanni2, Grace Qian2, Emily Banasiak2, Emily Kowalski2, yuqing zhang4, Jeffrey Sparks5 and Zachary Wallace3, 1Massachusetts General Hospital, Sale Creek, TN, 2Brigham and Women's Hospital, Boston, MA, 3Massachusetts General Hospital, Boston, MA, 4Massachusetts General Hospital, Quincy, MA, 5Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: Some patients with rheumatic disease on DMARDs may be at increased risk of poor response to SARS-CoV-2 vaccines and thus breakthrough COVID-19 infections. We…
  • Abstract Number: 0779 • ACR Convergence 2022

    Early Experience of Breakthrough COVID-19 Infections in Patients Who Received Pre-exposure Prophylaxis with Tixagevimab/cilgavimab

    Cassandra Calabrese1, Elizabeth Kirchner2, alexandra villa forte2, Rula Hajj-Ali3, Carol Langford4, james Fernandez2, Alise Carlson2, Brandon Moss2, Vickie Sayles4, Andrea Pallotta2, Alice kim2 and Leonard Calabrese4, 1Cleveland Clinic Foundation, Cleveland Heights, OH, 2Cleveland Clinic Foundation, Cleveland, OH, 3Cleveland Clinic, Hunting Valley, OH, 4Cleveland Clinic, Cleveland, OH

    Background/Purpose: Patients receiving B cell depleting therapies (BCDT) for immune mediated inflammatory diseases (IMIDs) have high risk of poor COVID-19 outcomes and strategies for COVID-19…
  • Abstract Number: 0795 • ACR Convergence 2022

    Post-Acute COVID-19 Sequalae (PACS) with New-onset Rheumatological Complications

    Neel Thanavala1, Kiho Son2, Nardien Sedhom2, Snehal Somalwar3, Zil Patel1, Rameen Jamil2, Carmen Venegas2, Ashutosh Thakar2, Agnes Yuen4, Melanie Kjarsgaard2, Susan Waserman2, Mylinh Duong2, Parameswaran Nair2, Christopher Carlsten4, Maggie Larche2, Terence Ho2, Sarah Svenningsen2, KONSTANTINOS TSELIOS5 and Manali Mukherjee2, 1The Research Institute of St. Joe's Hamilton, Hamilton, ON, Canada, 2McMaster University, Hamilton, ON, Canada, 3The Research Institute of St Joe's Hamilton, Hamilton, ON, Canada, 4University of British Columbia, Vancouver, BC, Canada, 5McMaster University, Population Health Research Institute, Hamilton, ON, Canada

    Background/Purpose: Post-Acute Sequalae of COVID-19 (PASC), prevalent in ~20-30% of convalescent COVID-19 patients is characterized by new/persistent symptoms after the initial recovery. Certain autoantibodies have…
  • Abstract Number: 0993 • ACR Convergence 2022

    SARS-CoV-2 Vaccine Side Effects and Infections in SLE

    Laura Yan1, Arielle Mendel2, Evelyne Vinet2, Fares Kalache3, Jennifer Lee1, Popi Panaritis2 and Sasha Bernatsky1, 1Research Institute of the McGill University Health Centre, Montréal, QC, Canada, 2McGill University Health Centre, Montréal, QC, Canada, 3McGill University Health Center, Montréal, QC, Canada

    Background/Purpose: SLE patients are an especially vulnerable population in the face of the COVID pandemic due to their dysregulated endogenous immune system, further downregulated by…
  • Abstract Number: 1341 • ACR Convergence 2022

    Clinical Outcomes of COVID-19 Vaccination and Booster in Patients with Autoimmune Inflammatory Rheumatic Diseases

    Silera Holguin Balbuena, Anna Radisic, Sarah Goodman, Shreya Gor, Beatrice Wood, Alexander Shahin, Kelara Samuel, Rahul Mhaskar and John Carter, University of South Florida, Tampa, FL

    Background/Purpose: The spread of COVID-19 began in December 2019 and quickly escalated into a global pandemic resulting in millions of deaths. Many factors are associated…
  • Abstract Number: 1778 • ACR Convergence 2022

    More Than Half of RA Patients with a Lifetime History of Mood Disorders or Anxious and Depressed During COVID-19 Pandemic

    Susan Bartlett1, orit schieir2, Marie-France Valois2, Diane Tin3, Glen Hazlewood4, Louis Bessette5, Gilles Boire6, Carol Hitchon7, Janet Pope8, Carter Thorne9 and Vivian Bykerk10, 1McGill University, Montreal, QC, Canada, 2McGill University, Montréal, QC, Canada, 3The Arthritis Program Research Group, Newmarket, ON, Canada, 4University of Calgary, Calgary, AB, Canada, 5Centre de l'Ostoporose et de Rhumatologie de Québec, Québec, QC, Canada, 6Universite de Sherbrooke, Sherbrooke, QC, Canada, 7University of Manitoba, Winnipeg, MB, Canada, 8University of Western Ontario, London, ON, Canada, 9Southlake Regional Health Centre, Newmarket, ON, Canada, 10Hospital for Special Surgery, New York, NY

    Background/Purpose: Chronic stress and chronic disease are risk factors for anxiety and depression. In Canadians with RA, pandemic-related stress was exacerbated by delayed access to…
  • Abstract Number: 1961 • ACR Convergence 2022

    COVID-19 mRNA Vaccine Induced Antibody Titers and IFN-g Responses Are Decreased in Persons with Rheumatoid Arthritis and Older Age

    Holly Dudley1, megan O'Mara2, Ann Auma1, Jenny Gong3, Yael Ross4, Natalie Gurevich2, Larraine Gordesky5, Nora Singer6, Lenche Kostadinova7, Brigid Wilson7, David Zidar7, Christopher King1, David Canaday1, Carey Shive1, Maya Mattar8 and Donald Anthony9, 1Case Western Reserve University, Cleveland, OH, 2Cleveland Veteran Affairs Medical Center, Cleveland, OH, 3Case Western School of Medicine, Cleveland, OH, 4Case Western Reserve University at MetroHealth Medical Center, Atlanta, GA, 5MetroHealth Medical Center, Cleveland, OH, 6The MetroHealth System at Case Western Reserve University School of Medicine, Cleveland, OH, 7VA Medical Center, Cleveland, OH, 8Louis Stokes VA Medical Center, Mayfield Heights, OH, 9Case, VA, Metro, Chardon, OH

    Background/Purpose: People with autoimmune diseases have worse outcomes if infected by SARS-CoV2. In particular, persons with rheumatoid arthritis (RA), have lower antibody responses to COVID-19…
  • Abstract Number: 2275 • ACR Convergence 2022

    Three Dose SARS-CoV-2 Vaccination Is Associated with Reduced Risk of Breakthrough COVID-19 During Omicron Wave in Patients with Autoimmune Diseases

    Caoilfhionn Connolly1, Rachel Wallwork1, Teresa Po-Yu Chiang1, Mayan Teles1, Jennifer Alejo1, Allan Massie2, Ami Shah3, Jemima Albayda1, Lisa Christopher-Stine1, Dorry Segev2, William Werbel1 and Julie Paik1, 1Johns Hopkins University, Baltimore, MD, 2NYU Langone Health, New York, NY, 3Johns Hopkins Rheumatology, Baltimore, MD

    Background/Purpose: While SARS-CoV-2 vaccination mitigates the risk of severe COVID-19, vaccinated patients with autoimmune diseases are more susceptible to infection despite vaccination ("breakthrough" COVID-19) and…
  • Abstract Number: 0082 • ACR Convergence 2022

    Impact of the COVID-19 Pandemic on Healthcare Utilization Among Rheumatoid Arthritis, Psoriatic Arthritis and Systemic Lupus Erythematosus Patients

    Jean Park, W. Cliff Rutter, Will Cavers, Elisea Avalos-Reyes and Kjel Johnson, CVS Health, Lincoln, RI

    Background/Purpose: Patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and systemic lupus erythematosus (SLE) are considered at risk for serious COVID infections due to their…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 29
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences